[go: up one dir, main page]

ES8202357A1 - Un procedimiento para preparar una vacuna de virus de la ra-bia inactivados - Google Patents

Un procedimiento para preparar una vacuna de virus de la ra-bia inactivados

Info

Publication number
ES8202357A1
ES8202357A1 ES500199A ES500199A ES8202357A1 ES 8202357 A1 ES8202357 A1 ES 8202357A1 ES 500199 A ES500199 A ES 500199A ES 500199 A ES500199 A ES 500199A ES 8202357 A1 ES8202357 A1 ES 8202357A1
Authority
ES
Spain
Prior art keywords
vaccine
inactivated
rabies virus
virus
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES500199A
Other languages
English (en)
Other versions
ES500199A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp SRL
Original Assignee
Norden Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norden Laboratories Inc filed Critical Norden Laboratories Inc
Publication of ES8202357A1 publication Critical patent/ES8202357A1/es
Publication of ES500199A0 publication Critical patent/ES500199A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/819—Viral vaccine for feline species, e.g. cats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR UNA VACUNA DE VIRUS DE LA RABIA INACTIVADO, A PARTIR DE CULTIVOS DE CELULAS TESTICULARES DE CERDOS. EL VIRUS DE LA RABIA QUE SE UTILIZA ES LA CEPA DE VIRUS DE RABIA DE ALTAS PASADA EN CULTIVO CELULAR HCP-SAD. SE HACE PASAR EL VIRUS. DE 6 A 12 PASADAS APROXIMADAMENTE, POR CULTIVOS CELULARES DE MAMIFEROS, TALES COMO CULTIVOS DE CELULAS DE RIÑON DE BOVINO. TRAS CRECER EN CELULAS DE TESTICULOS DE CERDO DE 34 A 38 C, SE INACTIVA CON UN AGENTE INACTIVADOR QUE NO DESTRUYA LAS PARTICULAS DE VIRUS O EL CARACTER ANTIENICO. PARA PREPARAR LA VACUNA SE COMBINA EL VIRUS DE RABIA CON UN AUXILIAR, UN VEHICULO ADECUADO Y/O UN ESTEBILIZADOR. COMO ESTABILIZADOR SE PUEDE EMPLEAR UN GEL DE HIDROXIDO DE ALUMINIO. LA VACUNA ES PARTICULARMENTE UTIL PARA VACUNAR PERROS Y GATOS.
ES500199A 1980-07-30 1981-03-09 Un procedimiento para preparar una vacuna de virus de la ra-bia inactivados Granted ES500199A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/174,306 US4347239A (en) 1980-07-30 1980-07-30 Inactivated rabies vaccine for veterinary use

Publications (2)

Publication Number Publication Date
ES8202357A1 true ES8202357A1 (es) 1982-01-16
ES500199A0 ES500199A0 (es) 1982-01-16

Family

ID=22635689

Family Applications (1)

Application Number Title Priority Date Filing Date
ES500199A Granted ES500199A0 (es) 1980-07-30 1981-03-09 Un procedimiento para preparar una vacuna de virus de la ra-bia inactivados

Country Status (14)

Country Link
US (1) US4347239A (es)
EP (1) EP0044920B1 (es)
JP (1) JPS5732227A (es)
KR (1) KR840001514B1 (es)
AU (1) AU544338B2 (es)
CA (1) CA1183452A (es)
DE (1) DE3160560D1 (es)
ES (1) ES500199A0 (es)
HK (1) HK50184A (es)
IE (1) IE50889B1 (es)
NZ (1) NZ196214A (es)
PH (3) PH17383A (es)
SG (1) SG3384G (es)
ZA (1) ZA811042B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664912A (en) * 1984-10-01 1987-05-12 Wiktor Tadeusz J Process for the large scale production of rabies vaccine
DE3526809A1 (de) * 1985-07-26 1987-04-02 Behringwerke Ag Tollwut-lebendimpfstoff
EP0222974B1 (de) * 1985-11-22 1991-11-13 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Verfahren zur Herstellung eines Tollwutimpfstoffes und nach diesem Verfahren erhaltener Impfstoff
US4990367A (en) * 1987-03-09 1991-02-05 Diamond Scientific Company Canine distemper virus vaccine
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
CN101846683B (zh) * 2010-06-22 2014-08-06 普莱柯生物工程股份有限公司 一种猪瘟活疫苗效力检验方法
RU2537183C2 (ru) * 2012-12-17 2014-12-27 Открытое Акционерное Общество "Институт Биотехнологий Ветеринарной Медицины" Способ получения инактивированной антирабической вакцины при безопорном выращивании клеток и репродукции в них вируса в укороченном цикле культивирования

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1030516B (de) * 1957-03-14 1958-05-22 Dr Med Gustav Seiffert Naehrboden zur Viruszuechtung
US3155589A (en) * 1958-04-14 1964-11-03 Upjohn Co Parenteral extravascular injectable vaccines for simultaneous immunization of canidae against rabies, canine distemper, and infectious canine hepatitis
US3397267A (en) * 1964-09-21 1968-08-13 Research Corp Method of producing rabies vaccine
US3423505A (en) * 1964-10-31 1969-01-21 Univ Toronto Rabies vaccine and process for preparation thereof
US3585266A (en) * 1969-02-24 1971-06-15 Dow Chemical Co Live rabies virus vaccine and method for the production thereof
US3769415A (en) * 1969-06-04 1973-10-30 Connaught Labor Ltd Method of preparing a killed vaccine for oral use
DE2162013C3 (de) 1971-12-14 1981-10-15 Johnson & Johnson, 08903 New Brunswick, N.J. Tollwut-Lebendimpfstoff, Verfahren zu seiner Herstellung nd seine Verwendung bei der Bekämpfung von Tollwut
FR2290220A2 (fr) 1974-11-05 1976-06-04 Pasteur Institut Nouveau vaccin antirabique
FR2261779A1 (en) 1974-02-26 1975-09-19 Pasteur Institut Anti-rabies vaccine - obtd. from rabies virus grown on foetal calf kidney cells in a synthetic serum-free medium
US4040904A (en) * 1975-07-21 1977-08-09 Slater Eban A Novel rabies virus vaccine and processes
DE2616407C3 (de) * 1976-04-14 1980-02-21 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Tollwut-Impfstoffs
US4070453A (en) * 1976-06-25 1978-01-24 Syntex (U.S.A.) Inc. Diploid porcine embryonic cell strains, cultures produced therefrom, and use of said cultures for production of vaccines
GB1596653A (en) 1977-01-26 1981-08-26 Gist Brocades Nv Vaccine
BE859178A (fr) 1977-09-29 1978-01-16 Cutter Lab Souche de cellules et culture de virus

Also Published As

Publication number Publication date
JPH0555487B2 (es) 1993-08-17
DE3160560D1 (en) 1983-08-11
IE50889B1 (en) 1986-08-06
EP0044920A2 (en) 1982-02-03
AU544338B2 (en) 1985-05-23
IE810240L (en) 1982-01-30
EP0044920B1 (en) 1983-07-06
SG3384G (en) 1985-02-01
US4347239A (en) 1982-08-31
PH18743A (en) 1985-09-16
ZA811042B (en) 1982-05-26
AU6714381A (en) 1982-02-04
JPS5732227A (en) 1982-02-20
CA1183452A (en) 1985-03-05
KR830005871A (ko) 1983-09-14
HK50184A (en) 1984-06-29
KR840001514B1 (ko) 1984-09-29
ES500199A0 (es) 1982-01-16
NZ196214A (en) 1984-07-31
PH22308A (en) 1988-07-22
EP0044920A3 (en) 1982-02-17
PH17383A (en) 1984-08-06

Similar Documents

Publication Publication Date Title
Singh et al. Time-scale and nature of radiation-biological damage: approaches to radiation protection and post-irradiation therapy
ES8301640A1 (es) Procedimiento para la preparacion de un producto para el tratamiento de heridas a base de un polimero organico hinchable
BRPI0407636A (pt) meio de cultura de células, linhagem de células animais, métodos para produzir um meio de cultura condicionado, células animais, uma cultura de células animais, vìrus em uma cultura de células animais, ou, de preferência, humanas diplóides dependentes de ancoragem, método para produzir uma vacina, e, população de vìrus
BR9814568A (pt) "inseminação sexual especìfica de mamìferos com baixo número de células espermatozóides"
ES2148323T3 (es) Sistema de expresion de un gen a base de geminivirus.
ATE482267T1 (de) Tierzellen und verfahren für die replikation von influenza viren
BR9708387A (pt) Processo para vacinação de um mamìfero a um antìgeno selecionado, células patogênica e hospedeira, composição de vacina, ácido nucleico, e, opsonina engenheirada.
FI932678A0 (fi) Pao alfavirus baserande DNA expressionssystem
EP0484374A4 (en) Rapid, versatile and simple system for expressing genes in eukaryotic cells
ES8602420A1 (es) Procedimiento para la preparacion de geles acuosos ambienta-dores
NO972935D0 (no) Forbedringer i eller vedrörende endometriefunksjon
AR004341A1 (es) Vacunas contra tumores y procedimiento para su produccion.
KR900700130A (ko) 종양전이의 면역요법용, 바이러스 변성 종양 백신과 그의 제조방법
ES2035818T3 (es) Mutantes de delecion de la timidin-kinasa del virus del herpes bovino-1, vacunas contra la rinotraqueitis bovina infecciosa que los contienen y metodos para su produccion y uso.
ES8202357A1 (es) Un procedimiento para preparar una vacuna de virus de la ra-bia inactivados
ES2074280T3 (es) Metodo para modificar el tropismo de celula, tejido o huesped de un microorganismo, microorganismos recombinantes obtenidos de este modo y su uso en medicina y medicina veterinaria.
ES2133612T3 (es) Metodo de recuperar energia de residuos solidos.
SE7512828L (sv) Calicivirusvaccin
AR220838A1 (es) Procedimiento para preparar una vacuna de virus de influenza(gripe);procedimiento de propagacion de virus de influenza y cultivo liquido de celulas inoculadas con dicho virus,de aplicacion exclusiva en dicho procedimiento para preparar dicha vacuna
GB941019A (en) Improvements in and relating to the stability of anti-haemophilic globulin (factor viii)
GB2136815A (en) Broad spectrum plant protection from pathogens
GB878704A (en) Propagation of attenuated infectious canine hepatitis virus in trypsinized tissue cultures of pig kidney and the preparation of a vaccine therefrom
GB1039722A (en) Process for the manufacture of a foot-and-mouth disease vaccine containing a live virus
GB953992A (en) Vaccine products and method of preparing same
SU221479A1 (ru) Способ разрушени клеточных структур растительных и животных тканей

Legal Events

Date Code Title Description
PC1A Transfer granted

Owner name: PFIZER INC.